Access to prenatal exome sequencing for fetal malformations: A qualitative landscape analysis in the US
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Nuriye N Sahin-Hodoglugil und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Fra…. Hauptthemen laut MEDLINE: Ultrasonography, Prenatal, Abortion, Spontaneous. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NICHD NIH HHS, NHGRI NIH HHS, Doris Duke Charitable Foundation.
Abstract (Originalsprache)
Objective
There is increasing evidence supporting the clinical utility of next generation sequencing for identifying fetal genetic disorders. However, there are limited data on the demand for and accessibility of these tests, as well as payer coverage in the prenatal context. We sought to identify clinician perspectives on the utility of prenatal exome sequencing (ES) and on equitable access to genomic technologies for the care of pregnancies complicated by fetal structural anomalies.
Method
We conducted two focus group discussions and six interviews with a total of 13 clinicians (11 genetic counselors; 2 Maternal Fetal Medicine/Geneticists) from U.S. academic centers and community clinics.
Results
Participants strongly supported ES for prenatal diagnostic testing in pregnancies with fetal structural anomalies. Participants emphasized the value of prenatal ES as an opportunity for a continuum of care before, during, and after a pregnancy, not solely as informing decisions about abortions. Cost and coverage of the test was the main access barrier, and research was the main pathway to access ES in academic centers.
Conclusion
Further integrating the perspectives of additional key stakeholders are important for understanding clinical utility, developing policies and practices to address access barriers, and assuring equitable provision of prenatal diagnostic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, California, USA.
- Center for Maternal-Fetal Precision Medicine, University of California San Francisco, San Francisco, California, USA.
- Division of Surgery, University of California San Francisco, San Francisco, California, USA.
- Department of Social & Behavioral Sciences, School of Nursing, University of California San Francisco, San Francisco, California, USA.
- Institute for Health & Aging, School of Nursing, University of California San Francisco, San Francisco, California, USA.
- Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Nuriye N Sahin-Hodoglugil, Teresa N Sparks
Förderung
- NICHD NIH HHS
- NHGRI NIH HHS
- Doris Duke Charitable Foundation
Zitieren
APA
Sahin-Hodoglugil, N. N., Lianoglou, B. R., Ackerman, S., Sparks, T. N., & Norton, M. E. (2023). Access to prenatal exome sequencing for fetal malformations: A qualitative landscape analysis in the US. Prenatal Diagnosis. https://doi.org/10.1002/pd.6444
Vancouver
Sahin-Hodoglugil NN, Lianoglou BR, Ackerman S, Sparks TN, Norton ME. Access to prenatal exome sequencing for fetal malformations: A qualitative landscape analysis in the US. Prenatal Diagnosis. 2023. doi:10.1002/pd.6444
BibTeX
@article{SahinHodoglugil2023,
author = {Sahin-Hodoglugil, Nuriye N and Lianoglou, Billie R and Ackerman, Sara and Sparks, Teresa N and Norton, Mary E},
title = {Access to prenatal exome sequencing for fetal malformations: A qualitative landscape analysis in the US},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6444}
}
EUVIMED